Literature DB >> 7211172

Vasopressin therapy in Parkinson's disease.

J P Jensen.   

Abstract

A double-blind crossover pilot study was carried out in six patients with Parkinson's disease in order to test the possible therapeutic effect of L-vasopressin after treatment for 1 month with 30 I.U. intranasally daily. The investigation was completed in five cases. No effects was noticed after LVP treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7211172     DOI: 10.1111/j.1600-0404.1980.tb03024.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Comparative physiological features of the regulatory effect of vasopressin on higher nervous activity in an ascending series of mammals.

Authors:  T N Sollertinskaya
Journal:  Neurosci Behav Physiol       Date:  1997 Nov-Dec

2.  Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.

Authors:  J Sundquist; M L Forsling; J E Olsson; M Akerlund
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

3.  The effects of vasopressin on memory processes in Java monkeys.

Authors:  T N Sollertinskaya; N N Korinkina
Journal:  Neurosci Behav Physiol       Date:  2000 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.